| Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome. TA Nuri E, Taraborelli M, Andreoli L, Tonello M, Gerosa M, Calligaro A ... immunol res, 2016 | 139* | 2016 |
| Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome CB Chighizola, F Pregnolato, L Andreoli, C Bodio, L Cesana, C Comerio, ... Journal of autoimmunity 90, 76-83, 2018 | 68 | 2018 |
| Long-term outcome of WHIM syndrome in 18 patients: high risk of lung disease and HPV-related malignancies L Dotta, LD Notarangelo, D Moratto, R Kumar, F Porta, A Soresina, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (5), 1568-1577, 2019 | 43 | 2019 |
| An integrated approach for a structural and functional evaluation of biosimilars: implications for erythropoietin A Gianoncelli, SA Bonini, M Bertuzzi, M Guarienti, S Vezzoli, R Kumar, ... BioDrugs 29, 285-300, 2015 | 35 | 2015 |
| Decreased circulating T regulatory lymphocytes in obese patients undergoing bariatric surgery C Agabiti-Rosei, V Trapletti, S Piantoni, P Airo, A Tincani, C De Ciuceis, ... PLoS One 13 (5), e0197178, 2018 | 33 | 2018 |
| Association between changes in BLyS levels and the composition of B and T cell compartments in patients with refractory systemic lupus erythematosus treated with belimumab F Regola, S Piantoni, T Lowin, S Archetti, R Reggia, R Kumar, ... Frontiers in pharmacology 10, 433, 2019 | 26 | 2019 |
| Biosimilars: regulatory status and implications across the world R Kumar, RB Malgarini, G Pimpinella, L Pani, S Pecorelli, M Memo Journal of Pharmacovigilance, 2015 | 23 | 2015 |
| Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept R Kumar, S Piantoni, M Boldini, E Garrafa, C Bazzani, M Fredi, R Ottaviani, ... Clin Exp Rheumatol 39 (1), 91-97, 2021 | 19 | 2021 |
| Reduction of CRKL expression in patients with partial DiGeorge syndrome is associated with impairment of T-cell functions M Giacomelli, R Kumar, A Soresina, N Tamassia, T Lorenzini, D Moratto, ... Journal of Allergy and Clinical Immunology 138 (1), 229-240. e3, 2016 | 19 | 2016 |
| α-and β-Papillomavirus infection in a young patient with an unclassified primary T-cell immunodeficiency and multiple mucosal and cutaneous lesions MM Landini, C Borgogna, A Peretti, E Colombo, E Zavattaro, R Boldorini, ... Journal of the American Academy of Dermatology 71 (1), 108-115. e1, 2014 | 17 | 2014 |
| FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma PM Sullivan, R Kumar, W Li, V Hoglund, L Wang, Y Zhang, M Shi, D Beak, ... Molecular cancer therapeutics 21 (10), 1608-1621, 2022 | 14 | 2022 |
| Clinical and prognostic significance of non-criteria antiphospholipid antibody tests ML Bertolaccini, O Amengual, B Artim-Eser, T Atsumi, PG de Groot, ... Antiphospholipid syndrome: current research highlights and clinical insights …, 2017 | 12 | 2017 |
| Autoantibodies’ titre modulation by anti-BlyS treatment in systemic lupus erythematosus I Cavazzana, R Kumar, C Pozzari, R Ottaviani, M Fredi, S Piantoni, ... Lupus 28 (9), 1074-1081, 2019 | 10 | 2019 |
| IL-4, IL-10 and TNF-α Polymorphisms in Idiopathic Membranous Nephropathy (IMN) M Giacomelli, R Kumar, G Tampella, S Ceffa, M Bontempelli Open Journal of Immunology 5 (05), 233, 2015 | 7 | 2015 |
| Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome R Kumar, S Milanesi, M Szpakowska, L Dotta, D Di Silvestre, AM Trotta, ... JCI insight 8 (5), 2023 | 4 | 2023 |
| G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2 F Bono, Z Tomasoni, V Mutti, G Sbrini, R Kumar, F Longhena, C Fiorentini, ... Biomolecules 13 (3), 473, 2023 | 2 | 2023 |
| CD22 CAR-T induces both CD19 and CD22 surface down-modulation: defining a mechanism of generalized immune evasion and the effects of epigenetic modifiers L Wang, Y Zhang, E Anderson, R Kumar, AJ Lamble, RJ Orentas Blood 136, 22-23, 2020 | 2 | 2020 |
| S7A: 6 Baseline serum levels of baff or april are independent predictors of sledai response after 12 months of treatment with belimumab in patients with refractory systemic … S Piantoni, L Andreoli, T Lowin, R Kumar, F Regola, P Airò, ... Lupus Science & Medicine 5 (Suppl 1), 2018 | 2 | 2018 |
| Development of FGFR4-targeted chimeric antigen receptors (CARs) for the treatment of rhabdomyosarcoma P Sullivan, R Kumar, W Li, L Wang, Y Zhang, A Cheuk, N Shivaprasad, ... Cancer Research 81 (13_Supplement), 1545-1545, 2021 | 1 | 2021 |
| P018 Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept M Fredi, M Boldini, R Kumar, S Piantoni, I Cavazzana, E Garrafa, ... Annals of the Rheumatic Diseases 78 (Suppl 1), A6-A7, 2019 | 1 | 2019 |
Angela TincaniReumatologia e Immunologia Clinica ERN ReCONNET - ASST Spedali Civili and University of BresciaVerified email at unibs.it
